Abstract

Abstract Background and Aims Microvascular inflammation (MVI) in kidney transplant (KT) biopsies from patients without detectable anti-HLA donor-specific antibodies (DSA) presents a diagnostic and therapeutic dilemma. This study aimed to further understand the significance of these changes by characterizing their molecular phenotype compared to other native and transplant kidney biopsies. Method The NanoString B-HOT panel (770 genes) was used to measure the expression of six literature-derived gene sets in 195 archival FFPE kidney biopsies from four centers, including transplant biopsies with MVI (g+ptc>1) but no detectable DSA (MVI, n = 47), antibody-mediated rejection with DSA (ABMR, n = 42), pure T-cell mediated rejection without DSA (TCMR, n = 25), mixed MVI and TCMR without DSA (MVI+TCMR, n = 47), normal implant biopsies (Normal, n = 11), and native kidney biopsies with either endocapillary proliferative glomerulonephritis (GN, n = 12) or minimal change disease (MCD, n = 11). The evaluated gene sets included transcripts previously associated with ABMR, DSA (DSAST), endothelial injury (ENDAT), TCMR, early injury, and late injury. Gene expression was compared between groups using principal component and class comparison analyses. Results Principal component analysis demonstrated significant molecular overlap between sample groups (Fig. 1A). However, gene set analysis showed lower expression of ABMR-related, DSAST (Fig. 1B), and ENDAT gene sets in DSA-negative MVI compared to ABMR. DSAST and ENDAT gene set expression was similar between MVI, MVI+TCMR, and TCMR groups; but higher than native biopsies (p ≤ 0.002). TCMR and early injury gene set expression was higher in TCMR than all other groups (p ≤ 0.002), except MVI+TCMR. Late injury gene set expression was lower in MVI compared to ABMR, MVI+TCMR, and TCMR groups (p ≤ 0.031); but higher than the Normal and MCD groups (p ≥ 0.016). Conclusion These results suggest that DSA-negative MVI displays a lower expression of ABMR-related genes than ABMR, but similar to MVI+TCMR and higher than native kidney biopsies with or without glomerulonephritis. Further work is underway to evaluate the potential role of non-HLA DSA and recognition of missing self in these cases.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.